A. Hajri et C. Damge, EFFECTS OF CHOLECYSTOKININ-OCTAPEPTIDE ON A PANCREATIC ACINAR CARCINOMA IN THE RAT, Pharmaceutical research, 15(11), 1998, pp. 1767-1774
Purpose. To investigate the effects of increasing concentrations of ch
olecystokinin octapeptide (CCK-8) on a pancreatic acinar adenocarcinom
a. Methods. Growth of the tumour was estimated in vivo on rats bearing
a subcutaneous pancreatic carcinoma, and in vitro on primary cultured
tumour cells. CCK receptors were characterized by binding assays. Res
ults. CCK-8, administered for 12 successive days, exerted a biphasic a
ction on tumour growth: a dose-dependent stimulation with low doses (0
.1 and 0.5 mu g/kg) and inhibition with high doses (2 and 4 mu g/kg) a
s shown by respective increases and decreases in tumor volume, protein
, RNA and amylase contents. In cell cultures, [H-3]thymidine incorpora
tion was dose-dependently increased with 10(-10) to 10(-8) M CCK-8 and
inhibited with 10(-7) M. Both effects were completely suppressed by t
he CCK-receptor antagonists CR 1409 and L 364,718 (10(-4) M). Binding
studies showed the overexpression of two classes of CCK-A receptors of
low and high affinity when compared to the normal pancreas which was
less sensitive to CCK-8. Conclusions. CCK-8 exerts a biphasic growth r
esponse on the acinar pancreatic carcinoma, mediated by two classes of
CCK-A receptors overexpressed in the tumour.